Open AccessToxicities, dose reduction and delay of docetaxel and paclitaxel chemotherapy in breast cancer without distant metastases
Author(s) -
Woo Young Kim,
Sang Uk Woo,
Jae Hong Seo,
Gil Soo Son,
Jae Bok Lee,
Jeoung Won Bae
Publication year - 2011
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.92004
Subject(s) - medicine , docetaxel , febrile neutropenia , neutropenia , breast cancer , cyclophosphamide , taxane , gastroenterology , oncology , regimen , chemotherapy , cancer , surgery
Docetaxel and paclitaxel are likely to have different toxicity profiles, dose reduction and delays despite their similar medical results in breast cancer patients.